Hunniwell Lake Ventures || News 

Hunniwell Shares Insights with UCLA BioDesign Program

May 27, 2020 ||  Hunniwell Lake Ventures Managing Partner Daniel Teo shares keen advice with the inaugural class of 2020 Fellows in the UCLA BioDesign Program in his presentation titled “Tales from the Other Side.” A  veteran medical device entrepreneur, innovator, and investor, Teo encourages the Fellows to take risks and brace for both the challenges and successes.

CoapTech Raises $7M in Series B Funding Led by Hunniwell, CoapTech CEOs shown above

Read more of Hunniwell’s Resources

On May 27th, 2020, Hunniwell Lake Ventures Managing Partner Daniel Teo shared his insights with the Fellows from the inaugural class of the UCLA BioDesign Fellowship Program. The presentation titled “Tales from the Other Side” aimed to take a light-hearted look at “horror stories” from both sides of the fence in the course of a VC investment into startups. Hunniwell is privileged to be a part of this journey towards excellence.

The UCLA BioDesign Fellowship unites stakeholders across the healthcare ecosystem to transform medicine through the development of novel technologies. The program works with industry partners and the medical community to advance solutions that deliver improved value and outcomes to patients worldwide.

In his presentation, Daniel shared advice with the Fellows. “As stewards of other people’s money, VCs face enormous pressures. … and some do not respond to it well. Every day lost is a fraction of an IRR shaved off a VC’s report card.”
Daniel Teo, Managing Partner of Hunniwell Lake Ventures

“As stewards of other people’s money, VCs face enormous pressures. … and some do not respond to it well. Every day lost is a fraction of an IRR shaved off a VC’s report card.”

– Daniel Teo, Managing Partner and Co-Founder of Hunniwell Lake Ventures

The BioDesign Fellowship Program is its second year and leadership combines experience in clinical innovation, medical technology development, entrepreneurship and care delivery.  The UCLA BioDesign team is supported by affiliate faculty from across the UCLA campus, including the David Geffen School of Medicine, Anderson School of Management, Henry Samueli School of Engineering and Applied Sciences, School of Dentistry, and School of Law.  Leading industry advisors support the BioDesign team across industry verticals through mentorship, resource allocation, and financial sponsorship.
With the mission to See, Treat, and Heal, Hunniwell is excited to be a part of this journey towards healthcare transformation centered in quality and excellence.

Hunniwell Lake Ventures (HLV) is a Palo Alto-based VC firm that invests exclusively in medical devices. Founded by Richard Fang and Daniel Teo, successful medical device entrepreneurs turned venture capitalists, Hunniwell Lake Ventures’ mission is to make surgery safer, more accessible, and less invasive by investing in surgical innovations that help medical providers See, Treat and Heal better.